PubMed

Safety monitoring with ocular anti-vascular endothelial growth factor therapies.

Fung AE, Bhisitkul RB.

Br J Ophthalmol. 2008 Dec;92(12):1573-4. No abstract available. PMID: 19029158 [PubMed - indexed for MEDLINE]Related articles

Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.

Emerson MV, Lauer AK.

BioDrugs. 2007;21(4):245-57. Review.PMID: 17628122 [PubMed - indexed for MEDLINE]Related articles

Pegaptanib sodium for the treatment of proliferative diabetic retinopathy and diabetic macular edema.

Giuliari GP, Guel DA, Gonzalez VH.

Curr Diabetes Rev. 2009 Feb;5(1):33-8. Review.PMID: 19199896 [PubMed - indexed for MEDLINE]Related articles

Inhibitors of ocular neovascularization: promises and potential problems.

van Wijngaarden P, Coster DJ, Williams KA.

JAMA. 2005 Mar 23;293(12):1509-13. Review. No abstract available. PMID: 15784876 [PubMed - indexed for MEDLINE]Related articles

Paracentesis before intravitreal injection of bevacizumab.

Tsui YP, Chiang CC, Tsai YY.

Can J Ophthalmol. 2008 Apr;43(2):239; author reply 239-40. No abstract available. PMID: 18347632 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.

Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, Goldbaum M, Guyer DR, Katz B, Patel M, Schwartz SD; Macugen Diabetic Retinopathy Study Group.

Ophthalmology. 2005 Oct;112(10):1747-57.PMID: 16154196 [PubMed - indexed for MEDLINE]Related articles

Incomplete posterior hyaloid detachment after intravitreal pegaptanib injection in diabetic macular edema.

Montero JA, Ruiz-Moreno JM, De La Vega C.

Eur J Ophthalmol. 2008 May-Jun;18(3):469-72.PMID: 18465737 [PubMed - indexed for MEDLINE]Related articles

[The current state and issues of medical treatment for age-related macular degeneration]

Ishida S.

Nippon Yakurigaku Zasshi. 2008 Jan;131(1):47-9. Japanese. No abstract available. PMID: 18187884 [PubMed - indexed for MEDLINE]Related articles

[Antiangiogenesis therapy of age-related macular degeneration]

Sjølie AK, Mortensen KK, Hansen MH.

Ugeskr Laeger. 2005 Aug 29;167(35):3267. Danish. No abstract available. PMID: 16138964 [PubMed - indexed for MEDLINE]Related articles

[Considerations about intravitreal triamcinolone use]

Gómez-Ulla F, López Gálvez MI.

Arch Soc Esp Oftalmol. 2007 Jun;82(6):327-9. Spanish. No abstract available. PMID: 17573639 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular endothelial growth factor Trap-Eye for diabetic macular oedema.

Kaiser PK.

Br J Ophthalmol. 2009 Feb;93(2):135-6. No abstract available. PMID: 19174397 [PubMed - indexed for MEDLINE]Related articles

[Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept]

Joussen AM.

Dtsch Med Wochenschr. 2007 Jun 8;132(23):1268-72. Review. German. PMID: 17541869 [PubMed - indexed for MEDLINE]Related articles

Treating age-related macular degeneration - interaction of VEGF-antagonists with their target.

Klettner A, Roider J.

Mini Rev Med Chem. 2009 Aug;9(9):1127-35. Review.PMID: 19689408 [PubMed - indexed for MEDLINE]Related articles

Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases.

Kaiser PK.

Am J Ophthalmol. 2006 Oct;142(4):660-8.PMID: 17011860 [PubMed - indexed for MEDLINE]Related articles

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.

Eyetech Study Group.

Retina. 2002 Apr;22(2):143-52.PMID: 11927845 [PubMed - indexed for MEDLINE]Related articles

Technology evaluation: pegaptanib, Eyetech/Pfizer.

Vinores SA.

Curr Opin Mol Ther. 2003 Dec;5(6):673-9.PMID: 14755895 [PubMed - indexed for MEDLINE]Related articles

Are intravitreal anti-VEGF antibodies safe?

Tezel TH, Kaplan HJ.

Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):1-2. No abstract available. PMID: 17365799 [PubMed - indexed for MEDLINE]Related articles

Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases.

Ng EW, Adamis AP.

Ann N Y Acad Sci. 2006 Oct;1082:151-71. Review.PMID: 17145936 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone for the treatment of diabetic macular edema.

Gómez-Ulla F, Marticorena J, Alfaro DV 3rd, Fernández M, Méndez ER, Rothen M.

Curr Diabetes Rev. 2006 Feb;2(1):99-112. Review.PMID: 18220620 [PubMed - indexed for MEDLINE]Related articles

Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice.

van Wijngaarden P, Qureshi SH.

Clin Exp Optom. 2008 Sep;91(5):427-37. Epub 2008 Jul 10. Review.PMID: 18637105 [PubMed - indexed for MEDLINE]Related articles